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The oxidation of low density lipoprotein (LDL) in vivo may result in its unregulated uptake 
by macrophages, with the consequent accumulation of cholesterol that is characteristic of the 
development of atherosclerosis. This paper describes initial experiments to elucidate struc- 
tural changes that occur in an in vitro model of LDL oxidation. LDL was isolated from 
human blood and oxidized in the presence of copper ion. Lipid was removed and the 
isolated apoprotein was subjected to tryptic hydrolysis. The hydrolysate was separated by 
high performance liquid chromatography and individual fractions were screened by amino 
acid analysis to detect cysteic acid residues. Appropriate fractions were analyzed by fast 
atom bombardment mass spectrometry and hybrid tandem mass spectrometry. In this 
manner a tryptic fragment was identified that corresponded to residues 4187-4195 
(EELCTMFIR), in which the cysteine and methionine residues were oxidized to cysteic acid 
and methionine sulfoxide, respectively. Identical analysis of LDL not subjected to in vitro 
oxidation revealed no evidence for this oxidized peptide. Earlier work established a surface 
location for this cysteine residue (Cys24) on the LDL particle, which suggested that its 
modification may significantly affect the properties of LDL, such as the propensity to 
intermolecular interaction via disulfide bridges. The analytical protocol developed here 
(involving proteolysis, screening of peptide fragments, and tandem mass spectrometry 
analysis) constitutes a strategy of general applicability to the characterization of targeted 
modifications of large proteins via mass spectrometry. (1 Am Sot Muss Spectrom 199.5, 6, 
242-247) 
L ow density lipoprotein (LDL) is a major contrib- utor to the development of atherosclerosis. There is now ample evidence, from both in vitro and in 
vivo experiments, that oxidative modification of LDL 
results in significant changes in biological properties 
[l]. Thus, oxidized LDL shows a reduced rate of cellu- 
lar uptake via the LDL receptor and an increased rate 
of uptake via both the scavenger (acetyl-LDL) receptor 
and a distinct oxidized-LDL receptor found on 
macrophages [2-51. These changes in receptor interac- 
tion can account for unregulated uptake of oxidized 
LDL by macrophages and accumulation of free and 
esterified cholesterol. Structural changes in apolipopro 
tein B-100 (apo B-100), the principal protein constituent 
of LDL, are thought to be responsible for the altered 
receptor-binding properties of oxidized LDL [6]. The 
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still poorly defined structural modifications of the pro- 
tein component of LDL that accompany oxidation are 
undoubtedly complex and may include direct oxida- 
tion of the protein as well as the formation of products 
of interaction of the protein and oxidized lipids. In 
addition, there is evidence for both protein cleavage 171 
and intermolecular cross-linking 18, 91 as a result of 
oxidation. 
The primary sequence of apo B-100 has been estab- 
lished from the complementary DNA sequence [lo-141 
and substantially confirmed by classical sequencing 
methods [14, 151. The locations of cystine bridges, free 
cysteine residues [16], and sites of glycosylation 1151 
also have been determined. Hunt et al. [ 171 have previ- 
ously reported the tandem mass spectrometry analysis 
of peptides obtained by a limited trypsin digestion 
of cyanogen bromide-treated apoprotein 8. In the re- 
search program of which the present report constitutes 
a part, the specific concern is with the characterization 
of structural modifications that accompany oxidation 
of LDL. Conventional protein analysis techniques are 
not readily applicable to the characterization of modi- 
fied proteins; accordingly, tandem mass spectrometry 
has been used here to analyze tryptic fragments of apo 
B-100 from oxidized LDL. This initial study has used 
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an in vitro model of the oxidation of LDL. Recognizing 
the expected complexity of structural changes that 
accompany LDL oxidation, the initial phase of this 
study has focused on a specific issue-the recognition 
and location of sites of oxidation of cysteine residues 
to cysteic acid. Because it is known that apo B-100 can 
be cross-linked to apolipoprotein (a) via disulfide bonds 
[18, 191, the possible modification of cysteine residues 
is relevant to the alteration of the biological properties 
of apo B-100 following oxidation. 
Experimental 
Preparation of Oxidized LDL 
LDL was isolated from the whole blood of three healthy 
human volunteer donors in accordance with standard 
procedures [20]. Plasma was separated from cells by 
centrifugation of whole blood at 5000 rev/min for 15 
min at 5 “C. By using appropriate densities of sodium 
chloride and potassium bromide solutions and ultra- 
centrifugation, each lipoprotein component of plasma 
(chylomicrons, very low density lipoprotein, interme- 
diate density lipoprotein, LDL, and high density 
lipoprotein) was isolated successively. LDL was thus 
purified by using a potassium bromide solution (den- 
sity 1.063) and ultracentrifugation at 55,000 rev/min 
for 15 h at 5 “C. The layer that contained purified LDL 
was dialyzed against tris-(hydroxymethyl)amino- 
methane hydrochloride buffer (pH 7.4) that contained 
ethylenediaminetetraacetic acid disodium salt for 24 h 
at 4 “C. 
Purified LDL was dialyzed against phosphate 
buffered saline (PBS; pH 7.4) for 24 h at 4 “C in the 
dark. The solution (approximately 15 mL of 5.8-mg/mL 
concentration of apo B-100, as judged by enzyme- 
linked immunosorbent assay) was diluted to an LDL 
concentration of about 2 mg/mL with PBS containing 
lo-PM copper sulfate. The diluted LDL solution (about 
40 mL) was transferred to two dialysis bags (Spec- 
traPor membranes, 12,000-14,000 u molecular weight 
cutoff; Spectrum Medical Industries, Houston, TX), 
which were immersed in 40 mL of lo-PM copper 
sulfate in PBS. Oxygen was bubbled through the solu- 
tion for 24 h at 45 “C. [In parallel studies (C.-Y. Yang, 
unpublished data) it has been established that oxida- 
tions at 37 and 45 “C effect a similar extent of total 
conversion of cysteine to cysteic acid, as judged by 
amino acid analyses of the total protein.] The LDL 
solution was then dialyzed against water for 24 h at 4 
“C and lyophilized. 
rated by centrifugation and washed with several por- 
tions of the chloroform-methanol solution. The precip- 
itates were dried under a stream of nitrogen and 
stored under nitrogen at -20 “C. 
Delipidated LDL (ape B-100; approximately 43 mg 
or 83 run011 was suspended in 3.5 mL of 0.1-M ammo- 
nium bicarbonate, pH 7.9. To the suspension was added 
1 mg of L-1-tosylamide-2-phenylethylchloromethyl 
ketone-treated trypsin. The mixture was stirred at 20 
“C for 24 h and was centrifuged at 3500 rev/min for 10 
mm. The supematant was stored at -20 “C. 
The supematant from the apo B-100 tryptic digest 
was separated by using a Vydac (Hesperia, CA) re- 
verse-phase Cl8 high performance liquid chromatogra- 
phy WJ?LC) column (4.6 X 200 mm) heated at 50 “C. 
The aqueous phase (A) was 0.1% trifluoroacetic acid 
(TFA) and the organic phase (B) was a 95/5 (v/v) 
mixture of acetonitrile and water that contained 0.08% 
TFA. The flow rate was 1.5 mL/min. Detection was by 
UV absorption at 220 run. The gradient used to collect 
fractions for amino acid analyses was from 0% B to 
70% B in 70 min and from 70% B to 100% B in the 
following 5 min. For this analysis a 25-PL aliquot of 
tryptic digest was injected (which corresponds to about 
0.6 nmol). Fractions were collected and dried under 
vacuum (Savant Speed-Vat Concentrator, Forma Scien- 
tific, Marietta, OH). An equivalent gradient was used 
for the collection of fractions for mass spectrometry 
analyses. Aliquots of 200 and 250 PL of tryptic digest 
were injected for a total volume of 1.65 mL (which 
corresponds to a maximum of approximately 39-run01 
protein). Fractions were collected, combined, and 
lyophilized. Each fraction was redissolved in 50 PL of 
a l/l (v/v> mixture of water and methanol for mass 
spectrometry analyses. Aliquots of 2 PL were used for 
each mass spectrometry analysis (which corresponds 
to a maximum of approximately 1.5 nmol). 
Amino Acid Analysis 
HPLC fractions obtained from the apo B-100 digest 
were placed in a vacuum container. To the container 
were added 400 PL of 6-M hydrochloric acid and 20 
PL of 0.02-M phenol. The container was then evacu- 
ated for 5 mm and heated at 150 “C for 70 min in a 
preheated oven. The hot container was opened to the 
atmosphere to remove hydrochloric acid vapors and 
placed under vacuum for 30 mm. To each dry fraction 
were added 20 PL of 0.4-N borate buffer (pH 10.4). 
Samples were vortex mixed, capped, and subjected to 
automated amino acid analysis. A Hewlett-Packard 
(Avondale, PA) 1090 HPLC for AminoQuant analysis 
was used. Aliquots (5 PL) of hydrolyzed apo B-100 
fractions in solution in 0.4-N borate buffer (pH 10.4) 
were automatically mixed in the injection loop with an 
additional 5-PL buffer, 1 PL of orthophthalaldehyde, 
and 1 PL of 9-fluoronylmethylchloroformate. The total 
volume was then injected onto an octadecylsilyl Hy- 
persil(5-pm) HPLC column (2.1 x 200 mm) (Gel Asso- 
Preparation and Typtic HydroZyhs of Apo B-100 
Lyophilized LDL was placed in a dessicator that con- 
tamed sodium hydroxide pellets and the dessicator 
was left under vacuum overnight. To each portion of 
dry LDL was added 5 mL of a 2/l (v/v> mixture of 
chloroform and methanol. Each precipitate was sepa- 
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ciates, Houston, TX) heated at 40 “C. The mobile phase 
and gradient elution profile were adjusted to optimize 
chromatographic separation of the cysteic acid deriva- 
tive. Thus, the eluting solvents consisted of 20-mM 
sodium acetate, 0.018% (v/v) triethylamine, 10m5-M 
ethylendiaminetetracetic acid disodium salt, adjusted 
to pH 6.3 with 1% acetic acid (solvent A), and 0.1-M 
sodium acetate adjusted to pH 7.2 with 1% acetic 
acid-methanol-acetonitrile (l/2/2, v/v/v; solvent B). 
The flow rate was 0.45 mL/min. The solvent program 
was from 0% B to 60% B in 17 mm, 60% B to 100% B 
in 1 min, isocratic at 100% B for 6 n-tin, and back to 0% 
B in 1 min. The column was then equilibrated for the 
next injection with 100% A for 8 min. Detection was by 
UV absorption with simultaneous and independent 
monitoring at 238 and 262 nm. 
Mass spectrometric analyses were performed on se- 
lected HPLC fractions. 
Results 
Mass Spectrometry 
All analyses were performed using a VG ZAB SEQ 
instrument (Fisons Instruments/VG Analytical, 
Manchester, UK) with the configuration BEqQ (mag- 
netic sector-electric sector-rf-only quadrupole- 
quadrupole mass filter). Ionization was by fast- 
atom bombardment (FAB), with B-keV xenon atoms 
used as the primary beam. The liquid matrix was 
thioglycerol-2,2’-dithiodiethanol (l/l, v/v), saturated 
with oxalic acid. Data were recorded via a VG 11-250 
data system. Conventional mass spectra were acquired 
(by scanning of Bl in centroided form; individual scans 
were of approximately 10-s duration. For tandem mass 
spectrometry analyses, precursor ions were selected at 
unit resolution by using BE and subjected to collisional 
activation in the rf-only quadrupole. The collision gas 
was argon at an estimated pressure of 1.6 to 3.4 x lo-” 
mbar (as judged from the recorded manifold pressure 
and the estimated conductance of the system). These 
conditions achieved an attenuation of the precursor ion 
beam of 50-60%. Product ion spectra were recorded 
by scanning Q, with total scan times of IO-15 s. The 
mass resolution of product ions was 1.5-2 u. Data 
were acquired by using the data system “multichannel 
analyzer” mode, with accumulation of lo-20 scans. In 
selected cases, tandem mass spectrometry data also 
were recorded after conversion of the appropriate pep- 
tide fraction to the N-acetyl derivative. The derivatiza- 
tion procedure was conducted on the FAB sample 
probe: to the liquid matrix were added 2 PL of the 
peptide mixture, dissolved in methanol and water 
(l/l), and 2 PL acetic anhydride. The reaction was 
allowed to proceed for 10 min at 20 “C before the probe 
was inserted into the mass spectrometer. 
Figure 1 shows the HPLC profile for the separation 
(with UV detection) of apo B-100 tryptic peptides from 
oxidized LDL. The highly complex pattern reflects the 
multitude of proteolytic cleavage points in a protein 
of this size (M, = 513 kDa). To screen for cysteic acid- 
containing fragments, 75 fractions (which correspond 
to elution time windows of between 0.6 and 1.5 min) 
were collected and subjected to automated amino acid 
analysis. The majority of such analyses revealed no 
evidence of the presence of cysteic acid. Figure 2 shows 
the amino acid analysis for the fraction collected be- 
tween 20.8 and 21.4 min. A minor peak was observed 
at approximately 2.6 min, which corresponds to the 
elution time of the authentic cysteic acid derivative. 
[The distortion of the I-IPLC peak fat 2.7 mm) that 
corresponds to the derivative of aspartic acid was not 
reproducibly observed. Its origin in this example is not 
clear.] The low abundance of the putative cysteic acid 
derivative peak, relative to the peaks that correspond 
to other amino acids, reflected in part the fact that the 
HPLC fraction was a complex mixture of tryptic frag- 
ments (see succeeding text), only one of which may 
have contained cysteic acid. Amino acid analysis of 
one other fraction (with an I-IPLC retention time of 
11.6-12.6 min> revealed the presence of cysteic acid at 
similar relative concentration. Seven other fractions 
provided tentative evidence for the presence of cysteic 
acid, but at a much lower relative concentration. 
Figure 3 shows the fast atom bombardment-mass 
spectrometry (FAB-MS) analysis of the HPLC fraction 
with a retention time of 20.8-21.4 min; multiple con- 
stituents are evident. Tandem mass spectromehy anal- 
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A further sample of LDL (which corresponded to ap- 
proximately one third of the quantity used in the 
above procedures) was isolated and treated as de- 
scribed except that the oxidation step was omitted. 
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Figure 1. HPLC separation with UV absorbance detection of the 
tryptic digest of apo B-100 derived from oxidized LDL. The 
solvent gradient (%B) is indicated. See Experimental for details. 
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Figure 2. HPLC separation with UV absorbance detection of amino acid derivatives from the 
hydrolysis of the tryptic digest fraction with a HPLC retention time of 20.8-21.4 min (Figure 1). 
yses of individual constituents provided sufficient in- 
formation to allow mapping of eight components of 
this fraction onto the apo B-100 sequence; the results 
are summarized in Table 1. The underlined sections of 
each sequence indicate the proportion deduced from 
the tandem mass spectrometry data. Residues shown 
in Italic type indicate ambiguity with respect to the 
order of particular residues and/or the differentiation 
of leucine and isoleucine residues. With two excep- 
tions, each peptide constituent of this fraction corre- 
sponded to cleavage at expected sites of tryptic hydrol- 
ysis. The component with an [M + HI+ ion of m/z 
718 yielded product ions consistent with the sequence 
LIFDPN and therefore represented cleavage on the 
C-terminal side of an asparagine residue. There is 
literature precedent for a nonenzymatic cleavage of 
this type: it has been suggested that cleavage proceeds 
via initial succinimide formation with subsequent hy- 
100. 
362 
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Figure 3. FAB mass spectrum of the tryptic digest fraction with 
a HPLC retention time of 20.8-21.4 min (Figure 1). 
drolysis to yield a C-terminal asparagine [21]. The 
component with an [M + HI+ ion of m/z 777 and 
attributed to the sequence SFSIPVK follows a tyrosine 
residue in the apo B-100 sequence and therefore ap- 
pears to represent a product of combined chymotryptic 
and tryptic cleavage. It is likely that the appearance of 
Table 1. Peptides identified in a HPLC fraction (20.8-21.4-min 
retention time) of the tryptic digest of apo B-100 from 
oxidized LDL 
[M + Hlfa Peptide sequenceb 
621 LTIFK 
718c L/FDPNd 
777c .SFSIPVKe 
Residue numbers in 
apo B-l 00 sequence 
4009-4013 
632-637 
3691-3697 
1021 NNALDFVTK 3186-3194 
1058 LSILTDPDGKd 4425-4434 
1205 EELC*TM”FIR 4187-4195 
1242 ATGVLYDYVNK 4050-4060 
1406 LQTFLDDASPGDK’ 518-530 
a Mass-to-charge ratio of the protonated molecule. rounded down 
to the nearest integral value. 
bConventional single letter codes are used, except for: C’. cys- 
teic acid; M”, methionine sulfoxide. Underlined portions of the se- 
quence were deduced from the tandem mass spectrometry analy- 
sis alone. Amino acid codes in Italic type represent ambiguities of 
interpretation of the mass spectrometry data with respect to leucine 
and isoleucine isomers or the ordering of a pair of residues. 
“Sequence determined from tandem mass spectrometry of the 
underivatized peptide and of the N-acetyl derivative. 
dSequence follows an asparagine residue (according to the ex- 
pected apo B-100 sequence), which indicates nonenzymatic cleav- 
age. 
‘Sequence follows a ryrosine residue (according to the expected 
apo B-100 sequence), which indicates chymotryptic cleavage. 
‘Sequence follows a leucine residue (according to the expected 
apo B-100 sequence), which indicates chymotryptic cleavage. 
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products other than those predicted as a result of 
tryptic hydrolysis alone was promoted by the pro- 
longed hydrolysis time required to achieve efficient 
tryptic cleavage. 
The peptide constituent that yielded an [M + HI+ 
ion of m/z 1205 (Table 1) was of particular interest in 
view of the primary focus of this study on cysteic 
acid-containing components. Figure 4 shows the prod- 
uct ion spectrum obtained by tandem mass spectrome- 
try with low energy collision-activated dissociation 
(CAD). The C-terminal arginine residue was apparent 
readily from the Y; ion of m/z 175; all other product 
ions of significant abundance also were attributable to 
the Y,: series and were consistent with the sequence 
EELCTMFIR with oxidation of the cysteine and me- 
thionine residues to cysteic acid and methionine 
sulfoxide, respectively. This sequence corresponds to 
residues 4X37-4195 of apo B-100. 
The extraordinary clarity of the product ion spec- 
trum obtained for this example has prompted a de- 
tailed study of the fragmentation properties of syn- 
thetic peptides of related structure. Detailed findings 
are reported elsewhere [22]. In brief, the formation of 
multiple members of the Y,‘,’ series of ions appears to 
be promoted by a gas-phase interaction between the 
arginine and cysteic acid residues, which reduces 
the propensity for protonation exclusively at the C- 
terminal arginine. The resultant population of proto- 
nated precursor ions is heterogeneous with respect to 
the site of charge, with consequent promotion of cleav- 
age of each peptide bond. The energetics of bond 
cleavage and the relative basicities of the separating 
fragments favor charge retention on C-terminal prod- 
ucts. 
Tryptic hydrolysis and preparative HPLC separa- 
tion also were performed on apo B-100 from LDL not 
subjected to oxidation in vitro. The HPLC profile, 
obtained by UV absorbance detection, was substan- 
tially different from that observed for the oxidized 
protein, which attests to the complexity of the struc- 
tural changes that accompany oxidation. A fraction 
Figure 4. Product ion spectrum obtained by CAD of precursor 
ions of m/t 1205 during the tandem mass spectrometry analysis 
of the tryptic digest fraction with a HPLC retention time of 
20.8-21.4 min (Figure 1). 
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with a retention time of 20.8-21.4 min was collected 
and analyzed by FAB-MS. The spectrum included ions 
(JTI/Z 621, 1021, 1242) previously observed in the 
equivalent fraction derived from the oxidized protein, 
There was no evidence for a component that yielded 
III/Z 1205. FAB-MS analyses of preceding and follow- 
ing HPLC fractions similarly failed to reveal this com- 
ponent. 
Detailed mass spectrometry and tandem mass spec- 
trometry analyses were performed on a further fraction 
(with an HPLC retention time of 11.6-12.6 min) of the 
tryptic digest derived from oxidized LDL. As previ- 
ously noted, amino acid analysis provided evidence 
that this fraction also included a cysteic acid-contain- 
ing component. Eight components were identified (in- 
cluding one trypsin autolysis product); none, however, 
was identified as a cysteine- or cysteic acid-containing 
peptide. 
Discussion 
The work described here sought to detect and locate 
cysteic acid residues in apoprotein B-100 of oxidized 
LDL. The strategy involved screening by amino acid 
analysis of HPLC fractions derived from the tryptic 
digest of the oxidized protein. FAB-MS and hybrid 
tandem mass spectrometry were used to analyze frac- 
tions of interest. The particular value of tandem mass 
spectrometry in the present application derives from 
the facility for the determination of sequence without 
the prior isolation of individual peptide constituents 
and from the ability to recognize modified peptide 
structures. Hybrid tandem instruments have not been 
used as widely to analyze peptides derived from bio- 
logical sources (as opposed to authentic standards) as 
their widespread availability might suggest. For the 
present work, it is noteworthy that approximately unit 
mass resolution of precursor ions was used and that 
the resolution of product ions (1.5-2 u> was sufficient 
to differentiate readily between product ions of adja- 
cent integral mass. In certain instances, essentially 
complete sequence information was obtained. For most 
examples, sufficient partial sequences could be de- 
duced to permit mapping of the peptide onto the 
known apo B-100 sequence. The fragmentation proper- 
ties of protonated peptides following low energy colli- 
sion activation remain a subject of investigation [23]. It 
appears, however, that typical low energy fragmenta- 
tions are charge-site directed. It is well accepted that 
the differentiation of the isomeric leucine and 
isoleucine residues cannot be achieved on the basis of 
low energy fragmentations [24]. Such distinction can 
be made from cleavages of the amino acid residue side 
chains, fragmentation processes that have a high en- 
ergy requirement [251. High energy (kiloelectronvolt in 
the laboratory frame-of-reference) CAD of peptides can 
be performed by using hybrid instruments, albeit with 
significant sacrifice in performance by comparison with 
four sector instruments 1261. Such analyses were not, 
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however, required in the work reported here, which 
involves the recognition of known or modified tryptic 
peptides. 
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